Jason Bassetti
Lawyers

Filters
Five9 $650 million convertible senior notes offering
Davis Polk acted as special product counsel to the representatives of the initial purchasers in connection with a Rule 144A offering by Five9, Inc. of an aggregate principal amount of …
McKesson splits off interest in Change Healthcare
Davis Polk advised McKesson Corporation in connection with the offer by McKesson to exchange shares of McKesson common stock for shares of PF2 SpinCo, Inc. (“SpinCo”) common stock owned by…
Shockwave Medical $16.5 million supplemental term loan
Davis Polk advised Shockwave Medical, Inc. in connection with a $16.5 million supplemental term loan provided by Silicon Valley Bank. Shockwave Medical used a portion of the proceeds…
Davis Polk Advises Shockwave Medical, Inc. on Its $90 Million Public Offering
Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 2,481,781 shares of common stock for an aggregate price to the public of approximately $90 million. The…
Davis Polk Advises McKesson on Change Healthcare’s Initial Public Offering and Concurrent Equity Units Offering
Davis Polk advised McKesson Corporation on Change Healthcare Inc.’s SEC-registered initial public offering of 49,285,713 shares of its common stock at a price to the public of $13 per…
Davis Polk Advises Kitty Hawk Corporation on Its Formation of a Strategic Partnership with Boeing
Davis Polk advised Kitty Hawk Corporation on its formation of a strategic partnership with Boeing to collaborate on future efforts to advance safe urban air mobility. The strategic…
Davis Polk Advises Ultra Clean on Its Acquisition of Dynamic Manufacturing Solutions
Davis Polk advised Ultra Clean Holdings, Inc. on its acquisition of substantially all of the assets of Dynamic Manufacturing Solutions, LLC for $30.0 million in cash, subject to post…
Davis Polk Advises ShockWave Medical, Inc. on Its $111.4 Million Initial Public Offering
Davis Polk advised ShockWave Medical, Inc. on its SEC-registered initial public offering of 6,555,000 shares of common stock for an aggregate price to the public of approximately $111.4…
Sienna Biopharmaceuticals, Inc. $20 Million Common Stock Offering
Davis Polk advised the joint book-running managers in connection with a $20 million SEC-registered common stock offering by Sienna Biopharmaceuticals, Inc. The common stock is listed on the…
AtriCure, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an $88 million SEC-registered follow-on offering of 2,875,000…